06:00 UTC Charta Aetatis Cyberpunk

Newsletter Pro Sign in Early access Register
Aa · Display
Themes
Type size
Density
MorningStar Security is in early access. The wiki is open to everyone; the news desks open with a code. Have a code, or want launch notice?
Export
stub · 1 feed

chemogenetics

Neuroscience technique enabling remote control of specific neurons via designer drugs; entered human clinical trials in China for epilepsy, Parkinson's disease, and pain treatment.

News volume 1 story in 90 days
22 Aug: 0 stories23 Aug: 0 stories24 Aug: 0 stories25 Aug: 0 stories26 Aug: 0 stories27 Aug: 0 stories28 Aug: 0 stories29 Aug: 0 stories30 Aug: 0 stories31 Aug: 0 stories1 Sep: 0 stories2 Sep: 1 story3 Sep: 0 stories4 Sep: 0 stories5 Sep: 0 stories6 Sep: 0 stories7 Sep: 0 stories8 Sep: 0 stories9 Sep: 0 stories10 Sep: 0 stories11 Sep: 0 stories12 Sep: 0 stories13 Sep: 0 stories14 Sep: 0 stories15 Sep: 0 stories16 Sep: 0 stories17 Sep: 0 stories18 Sep: 0 stories19 Sep: 0 stories20 Sep: 0 stories21 Sep: 0 stories22 Sep: 0 stories23 Sep: 0 stories24 Sep: 0 stories25 Sep: 0 stories26 Sep: 0 stories27 Sep: 0 stories28 Sep: 0 stories29 Sep: 0 stories30 Sep: 0 stories1 Oct: 0 stories2 Oct: 0 stories3 Oct: 0 stories4 Oct: 0 stories5 Oct: 0 stories6 Oct: 0 stories7 Oct: 0 stories8 Oct: 0 stories9 Oct: 0 stories10 Oct: 0 stories11 Oct: 0 stories12 Oct: 0 stories13 Oct: 0 stories14 Oct: 0 stories15 Oct: 0 stories16 Oct: 0 stories17 Oct: 0 stories18 Oct: 0 stories19 Oct: 0 stories20 Oct: 0 stories21 Oct: 0 stories22 Oct: 0 stories23 Oct: 0 stories24 Oct: 0 stories25 Oct: 0 stories26 Oct: 0 stories27 Oct: 0 stories28 Oct: 0 stories29 Oct: 0 stories30 Oct: 0 stories31 Oct: 0 stories1 Nov: 0 stories2 Nov: 0 stories3 Nov: 0 stories4 Nov: 0 stories5 Nov: 0 stories6 Nov: 0 stories7 Nov: 0 stories8 Nov: 0 stories9 Nov: 0 stories10 Nov: 0 stories11 Nov: 0 stories12 Nov: 0 stories13 Nov: 0 stories14 Nov: 0 stories15 Nov: 0 stories16 Nov: 0 stories17 Nov: 0 stories18 Nov: 0 stories19 Nov: 0 stories
Snapshot
Field
neurotech 1 source
Nature
method 1 source
Maturity
pilot 1 source
Intelligence coverage

Chemogenetics is a neurotech method that enables remote control of specific neurons through designer drugs. The technique works by introducing engineered receptors into targeted neural populations, which respond selectively to synthetic ligands that do not affect endogenous biology.

The approach entered human clinical trials in China 1 for treatment of epilepsy, Parkinson's disease, and pain 1. These trials represent the pilot stage of clinical development 1, marking the transition from preclinical and animal research to human applications.

The method's therapeutic potential derives from its specificity—designer drugs can activate only the engineered receptors, allowing precise modulation of defined neural circuits without affecting other brain regions or systems. This selectivity addresses a fundamental challenge in neurology and psychiatry, where many treatments lack circuit-level precision.

Chemogenetics builds on earlier optogenetics approaches but substitutes pharmacological activation for optical control, eliminating the need for implanted light delivery systems and enabling non-invasive treatment. The designer drugs can cross the blood-brain barrier and reach deep brain structures, making it applicable to conditions requiring modulation of circuits not accessible to surface stimulation.

Facts 3

AttributeValueConfidenceSourcesCited
Field neurotech low 1 1
Nature method low 1 1
Maturity pilot low 1 1

Applications 1

  • treatment of epilepsy, Parkinson's disease, and pain

Advanced by 1

Based on 1

Frequently mentioned together 2

Sources 2

  1. The race to engineer new knobs for the human brain · Hacker News (YC)
  2. First human trials of designer protein therapies stun US neuroscientists · Hacker News (YC)
That's Cyber for today

Tomorrow's desk, in your inbox by 06:00 UTC. The week's best stories, every Sunday. The month that mattered, on the 1st.

Drawn from the 519 sources the paper read this month. Text and HTML, one-click unsubscribe, free.

How often
Your desks